These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 22013800

  • 1. [Study of xiaozhang recipe combined with lamivudine in treatment of 84 chronic viral hepatitis B patients with compensated liver cirrhosis].
    Zhou ZH, Li M, Huang LY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep; 31(9):1220-3. PubMed ID: 22013800
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients].
    Duan SH, Bao ZY, Yuan XD, Wang L, Liu MS.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):535-8. PubMed ID: 27386642
    [Abstract] [Full Text] [Related]

  • 3. [Effects of Fuzheng Huayu Capsule on the ratio of TGF-beta1/BMP-7 of chronic viral hepatitis B fibrosis patients of Gan-Shen insufficiency blood-stasis obstruction syndrome].
    Tang CL, Zhou Z, Shi WQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):20-4. PubMed ID: 22500384
    [Abstract] [Full Text] [Related]

  • 4. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
    Nishida T, Kobashi H, Fujioka S, Fujio K, Takaguchi K, Ikeda H, Kawaguchi M, Ando M, Araki Y, Higashi T, Shoji B, Takaki A, Iwasaki Y, Sakaguchi K, Shiratori Y, Yamamoto K.
    J Gastroenterol Hepatol; 2008 May; 23(5):794-803. PubMed ID: 18086120
    [Abstract] [Full Text] [Related]

  • 5. [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].
    Yang Q, Gong ZJ, Hu DF.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):515-9. PubMed ID: 19912686
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study on Baihua Xianglian detoxification recipe combined with adefovir dipivoxil in treating HBeAg positive chronic hepatitis].
    Qiu H, Mao DW, Wei AL.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):176-9. PubMed ID: 22574587
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic efficacy and quality of life investigation of traditional Chinese medicine-based therapy of chronic hepatitis B-related liver fibrosis].
    An J, Ni W, Qiao J.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):30-2. PubMed ID: 24721240
    [Abstract] [Full Text] [Related]

  • 8. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.
    Tseng PL, Lu SN, Tung HD, Wang JH, Changchien CS, Lee CM.
    J Viral Hepat; 2005 Jul; 12(4):386-92. PubMed ID: 15985009
    [Abstract] [Full Text] [Related]

  • 9. Lamivudine for patients with chronic hepatitis B and advanced liver disease.
    Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J, Cirrhosis Asian Lamivudine Multicentre Study Group.
    N Engl J Med; 2004 Oct 07; 351(15):1521-31. PubMed ID: 15470215
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic efficacy of combined application of lamivudine and bushen recipe in treating chronic hepatitis B and its influence on YMDD motif].
    Zhou F, Wang LT, Chen JJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Jun 07; 23(6):417-20. PubMed ID: 12872391
    [Abstract] [Full Text] [Related]

  • 11. A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection.
    Sharma YR, Miah AR, Saha SK, Mohammed S, Rahman M, Roy PK, Hasan M.
    Nepal Med Coll J; 2004 Dec 07; 6(2):106-11. PubMed ID: 16295739
    [Abstract] [Full Text] [Related]

  • 12. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
    Wang L, Yan J, Zhang ZH, Wang JB, Du YZ, Li XY, Wang YZ.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct 07; 12(10):585-8. PubMed ID: 15504286
    [Abstract] [Full Text] [Related]

  • 13. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study].
    Liu SY, Zhang YQ, Liu YL, Guo P, Zhou CM.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov 07; 33(11):1457-61. PubMed ID: 24483103
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
    Lim SG, Aung MO, Mak B, Sutedja D, Lee YM, Lee GH, Fernandes M, Low HC, Lai V, Dan YY.
    J Clin Gastroenterol; 2011 Oct 07; 45(9):818-23. PubMed ID: 21921845
    [Abstract] [Full Text] [Related]

  • 15. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    Manolakopoulos S, Triantos C, Theodoropoulos J, Vlachogiannakos J, Kougioumtzan A, Papatheodoridis G, Tzourmakliotis D, Karamanolis D, Burroughs AK, Archimandritis A, Raptis S, Avgerinos A.
    J Hepatol; 2009 Sep 07; 51(3):468-74. PubMed ID: 19616339
    [Abstract] [Full Text] [Related]

  • 16. [One year and half treatment with lamivudine in active cirrhosis resulting from chronic hepatitis B].
    Zeng WQ, Guo SH, Zhang DZ, Zhou Z, Ren H, Zhang QH, Wang ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 07; 11(3):176-8. PubMed ID: 12681069
    [Abstract] [Full Text] [Related]

  • 17. [Clinical and pathological study on effects of Qianggan Capsule combined lamivudine on hepatic fibrosis in patients with chronic hepatitis B].
    Wang H, Zhao YL, Xu KC.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Nov 07; 26(11):978-80. PubMed ID: 17186724
    [Abstract] [Full Text] [Related]

  • 18. Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B.
    Nikolaidis N, Vassiliadis T, Giouleme O, Tziomalos K, Grammatikos N, Patsiaoura K, Orfanou-Koumerkeridou E, Balaska A, Eugenidis N.
    Clin Transplant; 2005 Jun 07; 19(3):321-6. PubMed ID: 15877792
    [Abstract] [Full Text] [Related]

  • 19. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
    Hu YY, Liu P, Liu C.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan 07; 26(1):18-22. PubMed ID: 16466166
    [Abstract] [Full Text] [Related]

  • 20. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA, Bacon BR, Di Bisceglie AM.
    Liver Transpl; 2000 Nov 07; 6(6):715-20. PubMed ID: 11084057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.